Properties of a new radioiodinated antagonist for human vasopressin V2 and V(1a) receptors

European Journal of Pharmacology

Volumn 331, Issue 2-3, 1997, Pages 285-293

  Ala, Youssef ^a   Morin, Denis ^a   Mahé, Eve ^a   Cotte, Nathalie ^a   Mouillac, Bernard ^a   Jard, Serge ^a   Barberis, Claude ^a   Tribollet, Eliane ^b   Dreifuss, Jean Jacques ^b   Sawyer, Wilbur H ^c   Wo, Nga Ching ^d   Chan, W Y ^d   Kolodziejczyk, Aleksandra S ^e   Cheng, Ling Ling ^e   Manning, Maurice ^e  

^a INSERM   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c Surgeons of Columbia University ^*  (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Autoradiography; Vasopressin receptor antagonist, iodinated; Vasopressin V2 receptor, human

Indexed keywords

1 (BETA MERCAPTO BETA,BETA PENTAMETHYLENEPROPIONIC ACID) 2 O ETHYL TYROSINE 4 VALINE 9 TYROSYLAMIDE; OXYTOCIN RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BLOOD PRESSURE; CHO CELL; DISSOCIATION CONSTANT; DIURESIS; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE VASOPRESSIN; AUTORADIOGRAPHY; DIURESIS; DNA; HUMANS; INOSINE TRIPHOSPHATE; IODINE RADIOISOTOPES; RATS; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN;

EID: 0030814154     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01021-2     Document Type: Article

References (39)

1. Allison, N.L., Albright-Winslow, C.R., Brooks, D.P., Stassen, F.L., Huffman, W.F., Stote, R.M., Kinter, L.B., 1988. Species heterogeneity and antidiuretic hormone antagonists: What are the predictors? In: Cowley Jr., A.W., Liard, J.F., Ausiello, D.A. (Eds.), Vasopressin: Cellular and Integrative Functions. Raven Press, New York, NY, p. 207.
2. Barberis, C., Balestre, M.N., Jard, S., Tribollet, E., Arsenijevic, Y., Dreifuss, J.J., Bankowski, K., Manning, M., Chan, W.Y., Schlosser, S.S., Holsboer, F., Elands, J., 1995. Characterisation of a novel, linear radioiodinated vasopressin antagonist: An excellent radioligand for vasopressin Via receptors. Neuroendocrinology 62, 135.
3. Berridge, M.J., Downes, C.P., Hanley, M.R., 1982. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206, 587.
4. Birnbaumer, M., Seibold, M., Gilbert, S., Ishido, S., Barberis, C., Antaramian, A., Brabet, P., Rosenthal, W., 1992. Molecular cloning of the receptor for human antidiuretic hormone. Nature 357, 333.
5. 3H]lysine vasopressin to pig kidney plasma membranes. Relationship of receptor occupancy to adenylate cyclase activation. J. Biol. Chem. 248, 5922.
6. Bodanszky, M., Sheehan, J.T., 1964. Active esters and resins in peptide synthesis, Chem. Ind., 1423.
7. Chini, B., Mouillac, B., Ala, Y., Balestre, M.N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., Jard, S., Barberis, C., 1995. Tyr 115 is the key residue for determining agonist selectivity in the Via vasopressin receptor. EMBO J. 14, 2176.
8. Dekanski, J., 1952. The quantitative assay of vasopressin. Br. J. Pharmacol. 7, 567.
9. 2]OVT: A selective oxytocin receptor ligand. Eur. J. Pharmacol. 147, 197.
10. Guillon, G., Butlen, D., Cantau, B., Barth, T., Jard, S., 1982. Kinetic and pharmacological characterisation of vasopressin membrane receptors from human kidney medulla: Relation to adenylate cyclase activation. Eur. J. Pharmacol. 85, 291.
11. Innamorati, G., Sadeghi, H., Birnbaumer, M., 1996. A fully active nonglycosylated V2 vasopressin receptor. Mol. Pharmacol. 50, 467.
12. Jard, S., Lombard, C., Seyer, R., Aumelas, A., Manning, M., Sawyer, W.H., 1987. Iodination of vasopressin analogues with agonistic and antagonistic properties: Effects on biological properties and affinity for vascular and renal vasopressin receptors. Mol. Pharmacol. 32, 369.
13. 1 vasopressin receptors. J. Recept. Res. 9, 27.
14. Kimura, T., Tanizana, O., Mori, K., Brownstein, M.J., Okayama, H., 1992. Structure and expression of a human oxytocin receptor. Nature 356, 526.
15. Klein, U., Jurzak, M., Gerstberger, R., Fahrenholz, F., 1995. A new tritiated oxytocin receptor radioligand-synthesis and application for localization of central oxytocin receptors. Peptides 16, 851.
16. Lolait, S.J., O'Carroll, A.M., McBride, O.W., Konig, M., Morel, A., Brownstein, M.J., 1992. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357, 336.
17. Manning, M., 1968. Synthesis by the Merrifield method of a protected nonapeptide amide with the amino acid sequence of oxytocin. J. Am. Chem. Soc. 90, 1348.
18. Manning, M., Cheng, L.L., Stoev, S., Sawyer, W.H., Tribollet, E., Barberis, C., Wo, N.C., Chan, W.Y., 1995. In: Saito, T., Kurokawa, K., Yoshida, S. (Eds.), Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. Elsevier Science B.V., Amsterdam, pp. 21-38.
19. Manning, M., Misicka, A., Olma, A., Klis, W.A., Bankowski, K., Nawrocka, E., Kruszynski, M., Kolodziejczyk, A., Cheng, L.L., Seto, J., Wo, N.C., Sawyer, W.H., 1987. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors. J. Med. Chem. 30, 2245.
20. Manning, M., Nawrocka, E., Misicka, A., Olma, A., Klis, W.A., 1984. Potent and selective antagonists of the antidiuretic reponses to arginine vasopressin based on modifications of [1-(β-mercapto-β,β-cyclopentamethylene propionic acid), 2-D-isoleucine, 4-valine] arginine-vasopressin at position 4. J. Med. Chem. 27, 423.
21. Manning, M., Olma, A., Klis, W.A., Kolodziejczyk, A., Seto, J., Sawyer, W.H., 1982. Design of more potent antagonists of the antidiuretic response to arginine-vasopressin. J. Med. Chem. 25, 45.
22. Manning, M., Sawyer, W.H., 1993. Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. J. Recept. Res. 13, 195.
23. 3H] 1-desamino-8-D-Arginine vasopressin as a radioligand for vasopressin v2-receptor in rat kidney. Endocrinology 122, 1328.
24. Merrifield, R.B., 1964. Solid phase peptide synthesis. III. An improved synthesis of bradykinin. Biochemistry 2, 1385.
25. Moore, M.L., Huffman, W.F., Roberts, G.D., Rottschaefer, S., Sulat, L., Stefankiewicz, J.S., Stassen, F., 1984. Synthesis and characterization of iodinated vasopressin antagonists which retain high affinity for the vasopressin receptor. Biochem. Biophys. Res. Commun. 121, 878.
26. Morel, A., O'Carroll, A.M., Brownstein, M.J., Lolait, S.J., 1992. Molecular cloning and expression of a rat Via arginine vasopressin receptor. Nature 356, 523.
27. Munsick, R.A., 1960. Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues. Endocrinology 66, 451.
28. Rivier, J., Kaiser, R., Galyean, R., 1978. Solid-phase synthesis of somatostatin and glucagon-selective analogs in gram quantities. Biopolymers 17, 1927.
29. Salomon, Y., Londos, C., Rodbell, M., 1974. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541.
30. Sawyer, W.H., 1958. Differences in antidiuretic responses of rats to the intravenous administration of lysine and arginine vasopressins. Endocrinology 63, 694.
31. Schild, H.O., 1947. p A, a new scale of the measurement of drug antagonism. Br. J. Pharmacol. 2, 189.
32. 1a receptors. FEBS Lett. 282, 77.
33. Serradeil-Le Gal, C., Wagnon, J., Garcia, C., Lacour, C., Guiraudou, P., Christophe, B., Villanova, G., Nisato, D., Maffrand, J.P., Le Fur, G., Guillon, G., Cantau, B., Barberis, C., Trueba, M., Ala, Y., Jard, S., 1993. Biochemical and pharmacological properties of SR 49059, a new potent, non-peptide antagonist of rat and human vasopressin Via receptors. J. Clin. Invest. 92, 224.
34. 3H]-SK and F 101926. Mol. Pharmacol. 31, 267.
35. Stewart, J.M., Young, J.D., 1984. Solid Phase Peptide Synthesis. Pierce Chemical Co., Rockford, IL, p. 120.
36. Sugimoto, T., Saito, M., Mochizuchi, S., Watanabe, Y., Hashimoto, S., Kawashima, H., 1994. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J. Biol. Chem. 269, 27088.
37. Thibonnier, M., Auzan, C., Madhun, Z., Wilkins, P., Berti-Mattera, L., Clauser, E., 1994. Molecular cloning, sequencing and functional expression of a cDNA encoding the human Via vasopressin receptor. J. Biol. Chem. 269, 3304.
38. Tribollet, E., Barberis, C., Dreifuss, J.J., Jard, S., 1988. Autoradiographic localization of vasopressin and oxytocin binding sites in rat kidney. Kidney Int. 33, 959.
39. 4]AVP: An AVP V2 receptor antagonist radioligand. Peptides 12, 1195.